James Blackledge presented Capella Imaging at LSI USA ‘23 Emerging Medtech Summit.
Capella Imaging's device, FibroScint[P1] (Tc-99m F4A], is a fibrin-targeted, peptide compound labeled with the radioisotope technetium-99m (Tc-99m) for SPECT imaging.
Learn More: [ Ссылка ]
Our Next Event → LSI Europe '23 in Barcelona, Spain on September 18th - 22nd
Join us today → [ Ссылка ]
Follow us on social!
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
Subscribe to our YouTube: [ Ссылка ]
